AORT (Artivion Inc) Prakiraan pendapatan perusahaan

Tandha merek Artivion Inc (AORT)

Future sales volumes for Artivion, Inc. (AORT) demonstrate the impact of its monopoly on cryopreserved tissues and On-X stents, with the 0.48 mark characterizing this parameter. Rising demand for cardiac surgery is bolstered by strict FDA oversight and physician confidence in patents, while the company's environmental focus is based on rigorous sterility and the safe disposal of biomaterials.

AORT - Volume dodolan sing dikarepake perusahaan Artivion Corp ing rentang 04.07.2022 - 18.11.2026

Rincian analitis lan laporan data perusahaan Artivion Inc (AORT)

- rega saiki lan proyeksi nilai saham:
Analisis fundamental perusahaan:artivion.com
Produk merek CryoLife

Artivion, Inc. (AORT) provides hospitals with critical cardiac surgery materials, including transplant tissues and stents, ensuring stable demand. By analyzing the company's prospective sales dynamics, an investor gains a primary issuer screening tool that aggregates market transactions into a single trend, allowing for an assessment of future revenue potential and the determination of fundamental business stability through the context of current values without a deep audit.

Analisis perusahaan pesaing

Prakiraan pendapatan perusahaan Boston Scientific Corp (BSX)|EW - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan RMD (resmed.com)|PODD - Volume dodolan mangsa ngarep perusahaan|Zimmer Biomet Holdings, Inc. - Prakiraan volume dodolan|COO (The Cooper Companies) - Prakiraan pendapatan perusahaan|ALGN: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan GMED|TMDX (TransMedics Corp) - Prakiraan volume dodolan|ATEC Spine (ATEC) - Dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan ENOV|Volume dodolan mangsa ngarep perusahaan Integra LifeSciences IART|Prakiraan volume dodolan ESTA (establishmentlabs.com)|Prakiraan volume dodolan Beta Bionics, Inc. BBNX|IRMD - Prakiraan pendapatan perusahaan|EMBC: Prakiraan pendapatan perusahaan|TNDM (Tandem Diabetes Care) - Volume dodolan mangsa ngarep perusahaan|AxoGen, Inc. - Pendapatan mangsa ngarep perusahaan|SIBN (SI-BONE Medical) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Orthofix Medical OFIX|Volume dodolan mangsa ngarep perusahaan BVS (Bioventus Inc)|OrthoPediatrics Inc. (KIDS) - Prakiraan dodolan perusahaan|Treace Corp - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan Strata Critical Medical Inc SRTA|Carlsmed, Inc. - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan RxSight Inc RXST|ClearPoint Neuro (CLPT) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan STXS (Stereotaxis Corporation)|Prakiraan pendapatan perusahaan neurostar.com|Volume dodolan mangsa ngarep perusahaan Sight Sciences, Inc. (SGHT)|Prakiraan volume dodolan OBIO|ANIK - Volume dodolan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan InspireMD, Inc. NSPR|ZJYL: Prakiraan pendapatan perusahaan|VANI: Volume dodolan mangsa ngarep perusahaan|Xtant Medical Holdings, Inc. - Prakiraan volume pendapatan perusahaan|NeuroOne Corp (NMTC) - Prakiraan pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan Modular Med|Prakiraan pendapatan perusahaan myomo.com|Prakiraan pendapatan perusahaan COCH (Envoy Medical, Inc.)|Volume dodolan mangsa ngarep perusahaan VVOS (Vivos Therapeutics)|Prakiraan pendapatan perusahaan NVNO (enVVeno Medical Corp.)|Sintx Technologies, Inc. - Volume dodolan mangsa ngarep perusahaan|Tenon Medical Inc. (TNON) - Volume dodolan sing dikarepake perusahaan|LFWD - Prakiraan pendapatan perusahaan|AMIX (Autonomix Medical) - Prakiraan pendapatan perusahaan|IVF: Prakiraan volume dodolan|BBLG (Bone Biologics) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Axonics Inc.|Volume dodolan sing dikarepake perusahaan Biolase, Inc. BIOL|Prakiraan pendapatan perusahaan Dynatronics Corp. (DYNT)|FNA (Paragon 28 Corp) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan invobioscience.com INVO